RFC
BIO icon

Russell Frank Company’s Bio-Rad Laboratories Class A BIO Stock Holding History

Russell Frank Company’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$56.7M Buy
414,391
+20,800
+5% +$2.73M 0.1% 230
2015
Q4 		$54.9M Buy
393,591
+43,501
+12% +$6.03M 0.1% 243
2015
Q3 		$47M Buy
350,090
+30,878
+10% +$4.44M 0.09% 241
2015
Q2 		$48.1M Buy
319,212
+88,021
+38% +$12.6M 0.08% 286
2015
Q1 		$31.3M Sell
231,191
-142,572
-38% -$17.7M 0.06% 384
2014
Q4 		$45.6M Buy
373,763
+7,933
+2% +$913K 0.08% 279
2014
Q3 		$41.5M Buy
365,830
+23,827
+7% +$2.82M 0.07% 298
2014
Q2 		$39.5M Buy
342,003
+3,623
+1% +$442K 0.07% 309
2014
Q1 		$41.7M Sell
338,380
-25,240
-7% -$3.24M 0.07% 306
2013
Q4 		$45.3M Sell
363,620
-38,738
-10% -$4.72M 0.08% 275
2013
Q3 		$47.3M Buy
402,358
+48,415
+14% +$5.71M 0.08% 270
2013
Q2 		$39.7M Buy
+353,943
New +$41.5M 0.07% 317

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Russell Frank Company's BIO Position: Q1 2016 in Review

Russell Frank Company increased its Bio-Rad Laboratories Class A (BIO) stake by 5.3% in Q1 2016, buying an estimated $2.73M and bringing the position to 414,391 shares worth $56.7M. The position accounts for 0.1% of the portfolio, ranked #230.

Russell Frank Company first reported a position in BIO in Q2 2013 and has held it in 12 quarters since. 232 funds tracked by Wall St. Rank hold BIO as of Q1 2016.

  • Russell Frank Company held 414,391 shares of Bio-Rad Laboratories Class A worth $56.7M as of Q1 2016.
  • Russell Frank Company bought 20,800 Bio-Rad Laboratories Class A shares in Q1 2016, an estimated $2.73M.
  • Bio-Rad Laboratories Class A made up 0.1% of Russell Frank Company's portfolio in Q1 2016, its #230 holding.
  • Russell Frank Company first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 12 quarters since.
  • 232 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.